Transcranial Doppler screening in Nigerian children with sickle cell disease: A 10‐year longitudinal study on the SPPIBA cohort-Reference-Cited by-同舟云学术

Transcranial Doppler screening in Nigerian children with sickle cell disease: A 10‐year longitudinal study on the SPPIBA cohort

Published:2021-02 Issue:4 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Lagunju IkeOluwa A.¹²^ORCID,Labaeka Adeyemi¹²^ORCID,Ibeh Joy N.¹²^ORCID,Orimadegun Adebola E.¹²^ORCID,Brown Biobele J.¹²^ORCID,Sodeinde Olugbemiro O.¹²^ORCID

Affiliation:

1. Department of Paediatrics, College of Medicine University of Ibadan Ibadan Nigeria

2. Department of Paediatrics University College Hospital Ibadan Nigeria

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28906

Reference34 articles.

1. Cerebrovsacular accidents in sickle cell disease: rates and risk factors;Ohene‐Frempong K;Blood,1998

2. Big Strokes in Small Persons

3. Sickle cell disease;Meremikwu MM;BMJ Clin Evid,2011

4. World Health Organisation.Sickle Cell Anaemia: Report by the Secretariat.https://apps.who.int/iris/handle/10665/20890. Accessed August 5 2020.

5. Adverse neurological outcomes in Nigerian children with sickle cell disease

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)—A randomized, placebo‐controlled phase II feasibility/pilot study;American Journal of Hematology;2024-07-02

2. Sickle cell anemia and early stroke detection and prevention in Nigeria;Frontiers in Stroke;2024-06-19

3. Models of care for sickle cell disease in low-income and lower-middle-income countries: a scoping review;The Lancet Haematology;2024-04

4. Role of hydroxyurea therapy in the prevention of organ damage in sickle cell disease: a systematic review and meta-analysis;Systematic Reviews;2024-02-08

5. Most adults with severe HbSC disease are not treated with hydroxyurea;Blood Advances;2023-07-11